摘要
Metabolic disorders,including endocrine disorders,obesity,diabetes,cerebrocardiovascular disease,and even cancer,are the most common and lethal diseases with the leading all-cause mortality around the globe.[1]For example,according to the World Health Organization,type 2 diabetes mellitus(T2DM)as a chronic disease owing to insulin resistance became the ninth leading cause of death with 1.5 million deaths in 2019.[2]Currently,there are approximately 422 million people worldwide suffering from diabetes,with the majority living in low-and middle-income countries.[3]High T2DM prevalence has been associated with obesity and lifestyle factors such as lack of physical exercise,although genetic factors are linked to a subpopulation of T2DM patients.
基金
YC’s laboratory is supported through research grants from: the Swedish Research Council (Nos. 2011-04091, 2016-02215, and 2019-01502)
the Swedish Cancer Foundation (No. 200734PjF)
the Swedish Children’s Cancer Foundation (Nos. PR2015-0159 and PR2018-0107)
the Strategic Research Areas (SFO) -Stem Cell and Regenerative Medicine Foundation, the Karolinska Institute Foundation (No. 2020-02080)
the Karolinska Institute distinguished professor award
the NOVO Nordisk Foundation, Hong Kong Centre for Cerebrocardiovascular Health Engineering, Hong Kong, China
the Knut and Alice Wallenberg’s Foundation (No. KAW2014.0112) .